N-[4-[(4,5-Dihydro-6H-thieno[3,2-d][1]benzazepin-6-yl)carbonyl]-3-methoxyphenyl]-5-fluoro-2-methylbenzamide

1-(tert-Butyl) 2-ethyl 3-aminoazetidine-1,2-dicarboxylate

G-quadruplex ligand 1

4-(bromomethyl)-2-chloro-6-methoxyBenzaldehyde

Methyl 3-(2,2-dimethoxyethyl)-2-nitrobenzoate

(2S,3R,4R)-3-Fluoro-4-(hydroxymethyl)-1-(phenylmethyl)-2-azetidinecarboxylic acid

(2R,3S,4S)-3-Fluoro-4-(hydroxymethyl)-N-methyl-1-(phenylmethyl)-2-azetidinecarboxamide

(2S,3S,4S)-4-(Hydroxymethyl)-N-methyl-3-(phenylmethoxy)-1-(phenylmethyl)-2-azetidinecarboxamide

[5-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-[2-[[2-[2-(hydroxy-kappaO)-3,5-disulfophenyl]diazenyl-kappaN2](2-sulfophenyl)methyl]diazenyl-kappaN1]benzoato(6-)-kappaO]-cuprate(4-) sodium (1:4)

Cuprate(3-), [mu-[7-[2-[3,3'-di(hydroxy-kappaO)-4'-[2-[2-(hydroxy-kappaO)-6-sulfo-1-naphthalenyl]diazenyl-kappaN1][1,1'-biphenyl]-4-yl]diazenyl-kappaN1]-8-(hydroxy-kappaO)-1,6-naphthalenedisulfonato(7-)]]di-, sodium (1:3)

2-(2-Bromopropanoyl)-6-mercaptophenylacetic acid